BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3782127)

  • 1. Mechanism-based inhibition of dopamine beta-monooxygenase by aldehydes and amides.
    Bossard MJ; Klinman JP
    J Biol Chem; 1986 Dec; 261(35):16421-7. PubMed ID: 3782127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of isotope effects to characterize intermediates in mechanism-based inactivation of dopamine beta-monooxygenase by beta-chlorophenethylamine.
    Bossard MJ; Klinman JP
    J Biol Chem; 1990 Apr; 265(10):5640-7. PubMed ID: 2318829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism-based inactivation of dopamine beta-monooxygenase by beta-chlorophenethylamine.
    Mangold JB; Klinman JP
    J Biol Chem; 1984 Jun; 259(12):7772-9. PubMed ID: 6547439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of non-conjugated olefinic substrate analogues with dopamine beta-monooxygenase: catalysis and mechanism-based inhibition.
    Sirimanne SR; May SW
    Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):77-85. PubMed ID: 7864832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism-based inactivation of dopamine beta-hydroxylase by p-cresol and related alkylphenols.
    Goodhart PJ; DeWolf WE; Kruse LI
    Biochemistry; 1987 May; 26(9):2576-83. PubMed ID: 3607034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of dopamine beta-monooxygenase by external and internal electron donors in resealed chromaffin granule ghosts.
    Ahn NG; Klinman JP
    J Biol Chem; 1987 Feb; 262(4):1485-92. PubMed ID: 3805036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reduction of membrane-bound dopamine beta-monooxygenase in resealed chromaffin granule ghosts. Is intragranular ascorbic acid a mediator for extragranular reducing equivalents?
    Wimalasena K; Wimalasena DS
    J Biol Chem; 1995 Nov; 270(46):27516-24. PubMed ID: 7499210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of soluble and membrane bound dopamine-beta-monooxygenase from bovine adrenal medulla cross-linked with dimethyl suberimidate.
    Miras-Portugal MT; Millaruelo A; Vara F
    Mol Cell Biochem; 1980 Dec; 33(1-2):25-33. PubMed ID: 7207467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism-based inactivation of dopamine beta-monooxygenase in adrenal chromaffin cells.
    May SW; Young FK; Powers JL; Gill-Woznichak MM
    Biochem Biophys Res Commun; 1996 Nov; 228(2):278-84. PubMed ID: 8920906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism-based inhibitors of dopamine beta-hydroxylase: inhibition by 2-bromo-3-(p-hydroxyphenyl)-1-propene.
    Colombo G; Rajashekhar B; Giedroc DP; Villafranca JJ
    Biochemistry; 1984 Jul; 23(16):3590-8. PubMed ID: 6477886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism-based inhibitors of dopamine beta-hydroxylase.
    Fitzpatrick PF; Villafranca JJ
    Arch Biochem Biophys; 1987 Sep; 257(2):231-50. PubMed ID: 3662525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine beta-hydroxylase. Inactivation by a suicide substrate.
    Baldoni JM; Villafranca JJ
    J Biol Chem; 1980 Oct; 255(19):8987-90. PubMed ID: 7410403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous spectrophotometric assays for dopamine beta-monooxygenase based on two novel electron donors: N,N-dimethyl-1,4-phenylenediamine and 2-aminoascorbic acid.
    Wimalasena K; Wimalasena DS
    Anal Biochem; 1991 Sep; 197(2):353-61. PubMed ID: 1785690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of inactivation of dopamine beta-hydroxylase by hydrazines.
    Fitzpatrick PF; Villafranca JJ
    J Biol Chem; 1986 Apr; 261(10):4510-8. PubMed ID: 3007460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of dopamine-beta-monooxygenase with lipids: 1. Lipids as modulators of the catalytic activity of the enzyme.
    Boyadzhyan AS; Karagezyan KG
    Biomed Sci; 1990 Apr; 1(4):379-83. PubMed ID: 2133056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmembrane nature of chromaffin granule dopamine beta-monooxygenase.
    Zaremba S; Hogue-Angeletti RA
    J Biol Chem; 1981 Dec; 256(23):12310-5. PubMed ID: 6795200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purified cytochrome b561 catalyzes transmembrane electron transfer for dopamine beta-hydroxylase and peptidyl glycine alpha-amidating monooxygenase activities in reconstituted systems.
    Kent UM; Fleming PJ
    J Biol Chem; 1987 Jun; 262(17):8174-8. PubMed ID: 3597367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternate substrates of dopamine beta-hydroxylase. II. Inhibition by benzyl cyanides and reactivation of inhibited enzyme.
    Colombo G; Giedroc DP; Rajashekhar B; Villafranca JJ
    J Biol Chem; 1984 Feb; 259(3):1601-6. PubMed ID: 6693427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in situ kinetics of dopamine beta-hydroxylase in bovine adrenomedullary chromaffin cells. Intravesicular compartmentation reduces apparent affinity for the cofactor ascorbate.
    Menniti FS; Knoth J; Peterson DS; Diliberto EJ
    J Biol Chem; 1987 Jun; 262(16):7651-7. PubMed ID: 3584135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of dopamine-beta-monooxygenase with chromaffin granule membrane lipids.
    Pogosyan AG; Boyajian AS; Mkrtchyan MY; Karagezyan KG
    Biochem Biophys Res Commun; 1992 Oct; 188(2):678-83. PubMed ID: 1445313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.